Cited by 210HIV-related health complications and treatmentsDiabetes, Cardiovascular Risks, and LipoproteinsHIV/AIDS Research and Interventions

The DOI matches its Crossref record; 17 of the 18 references it cites were found in a registry or an index.

European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV*

Open access

Lundgren, JD, Battegay, M, Behrens, G, De Wit, S, Guaraldi, G, Katlama, C, Martinez, E, Nair, D, Powderly, WG, Reiss, P, Sutinen, J, Vigano, A, the EACS Executive Committee·2008·HIV Medicine

DOI 10.1111/j.1468-1293.2007.00534.x

Open this paper in CoChat — free account Open PDF

Abstract

Background: Metabolic diseases are frequently observed in HIV‐infected persons and, as the risk of contracting these diseases is age‐related, their prevalence will increase in the future as a consequence of the benefits of antiretroviral therapy (ART). Summary of guidelines: All HIV‐infected persons should be screened at regular intervals for a history of metabolic disease, dyslipidaemia, diabetes mellitus, hypertension and alteration of body composition; cardiovascular risk and renal function should also be assessed. Efforts to prevent cardiovascular disease will vary in intensity depending on an individual's absolute risk of ischaemic heart disease and should be comprehensive in nature. Lifestyle interventions should focus on counselling to stop smoking, modify diet and take regular exercise. A healthy diet, exercise and maintaining normal body weight tend to reduce dyslipidaemia; if not effective, a change of ART should be considered, followed by use of lipid‐lowering medication in high‐risk patients. A pre‐emptive switch from thymidine analogues is recommended to reduce the risk of development or progression of lipoatrophy. Intra‐abdominal fat accumulation is best managed by exercise and diet. Prevention and management of type 2 diabetes mellitus and hypertension follow guidelines used in the general population. When using medical interventions to prevent and/or treat metabolic disease(s), impairment of the efficacy of ART should be avoided by considering the possibility of pharmacokinetic interactions and compromised adherence. Specialists in HIV and specialists in metabolic diseases should consult each other, in particular in difficult‐to‐treat cases. Conclusion: Multiple and relatively simple approaches exist to prevent metabolic diseases in HIV‐infected persons; priority should be given to patients at high risk of contracting these diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1111/j.1468-1293.2007.00534.x

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Untitled work
Bantle (2008) · doi:10.2337/dc08-s061 · Cited by 1,795
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary
Rydén, L., Standl, E., Bartnik, M., den Berghe, G. V., Betteridge, J. D., de Boer, M., Cosentino, F., Jönsson, B., Laakso, M., Malmberg, K., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl260 · Cited by 1,644
Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease
Triant, V. A., Lee, H., Hadigan, C., & Grinspoon, S. K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2190 · Cited by 1,613
Class of Antiretroviral Drugs and the Risk of Myocardial Infarction
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa062744 · Cited by 1,521
Cardiovascular Risk and Body-Fat Abnormalities in HIV-Infected Adults
Grinspoon, S. K., & Carr, A. D. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041811 · Cited by 1,073
Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group
Dubé, M. P., Stein, J. H., Aberg, J. A., Fichtenbaum, C. J., Gerber, J. G., Tashima, K. T., Henry, W. K., Currier, J. S., Sprecher, D. L., & Glesby, M. J. (2003) · Clinical Infectious Diseases · doi:10.1086/378131 · Cited by 578
Guidelines for the Management of Chronic Kidney Disease in HIV-Infected Patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America
Gupta, S. K., Eustace, J. A., Winston, J. A., Boydstun, I. I., Ahuja, T. S., Rodriguez, R. A., Tashima, K. T., Roland, M. E., Franceschini, N., Palella, F. J., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/430257 · Cited by 577
Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy
Mallon, P. W. G., Miller, J., Cooper, D. A., & Carr, A. D. (2003) · AIDS · doi:10.1097/00002030-200305020-00005 · Cited by 313

Show all 18 references

Research works printed but not linked: 3

Ryden L, 2007, Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC); European Association for the Study of Diabetes (EASD). Guidelines on diabetes, pre‐diabetes, and cardiovascular diseases, Eur Heart J, 28, 88
American Diabetes Association., 2007, Position statement, standards of medical care in diabetes – 2007, 30, S48
Cifkova R, 2003, ESH/ESC Hypertension Guidelines Committee. Practice guidelines for primary care physicians, 2003 ESH/ESC hypertension guidelines, 21, 1779

Sorted by citations

Items 101–200 of 210

Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy
Study, S. H. C., Bucher, H. C., Rickenbach, M., Young, J., Glass, T. R., Vallet, Y., Bernasconi, E., Cavassini, M. L., Fux, C. A., Schiffer, V., et al. (2010) · Antiviral Therapy · doi:10.3851/imp1475 · Cited by 14
Self-citation
Diabetes and Infections
Cockram, C. S., & Wong, B. C. K. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch55 · Cited by 14
Addressing Cardiometabolic Challenges in HIV: Insights, Impact, and Best Practices for Optimal Management—A Narrative Review
Mugisha, N., Ghanem, L., Komi, O. A., Noureddine, R., Shariff, S., Wojtara, M. S., Nanehkeran, M. M., & Uwishema, O. (2025) · Health Science Reports · doi:10.1002/hsr2.70727 · Cited by 13
Diagnosing acute hepatitis C in HIV-infected patients: Nucleic acid testing compared with antibody and antigen–antibody detecting methods
Nastouli, E., Thomson, E. C., Karayiannis, P., Main, J., McClure, M. O., & Muir, D. A. (2008) · Journal of Clinical Virology · doi:10.1016/j.jcv.2008.09.008 · Cited by 13
Excess heart age in adult outpatients in routine HIV care
Thompson‐Paul, A. M., Palella, F. J., Rayeed, N., Ritchey, M. D., Lichtenstein, K. A., Patel, D., Yang, Q., Gillespie, C., Loustalot, F. V., Patel, P., et al. (2019) · AIDS · doi:10.1097/qad.0000000000002304 · Cited by 13
Pathophysiology and Clinical Management of Dyslipidemia in People Living with HIV: Sailing through Rough Seas
Papantoniou, E., Arvanitakis, K., Markakis, K., Papadakos, S. P., Tsachouridou, Ο., Popovic, D. S., Koufakis, T., Germanidis, G. S., & Kotsa, K. (2024) · Life · doi:10.3390/life14040449 · Cited by 14
Different strategies of 25OH vitamin D supplementation in HIV-positive subjects
Falasca, K., Ucciferri, C., Nicola, M. D., Vignale, F., Biase, J. D., & Vecchiet, J. (2014) · International Journal of STD & AIDS · doi:10.1177/0956462414520804 · Cited by 12
Metabolic syndrome in HIV-positive patients
Drelichowska, J., Kwiatkowska, W., Knysz, B., & Witkiewicz, W. (2014) · HIV & AIDS Review · doi:10.1016/j.hivar.2014.09.002 · Cited by 12
Heart failure in HIV infection
Ng, B., MacPherson, P., Haddad, T., & Dwivedi, G. (2014) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000041 · Cited by 12
Lipid Management in Human Immunodeficiency Virus
Myerson, M. L. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.09.010 · Cited by 12
Biomarkers and Prevalence of Cardiometabolic Syndrome Among People Living With HIV/AIDS, Addis Ababa, Ethiopia: A Hospital-Based Study
Woldu, M. A., Minzi, O., Shibeshi, W., Shewaamare, A., & Engidawork, E. (2022) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/11795514221078029 · Cited by 12
Antiretroviral Therapy With Heart
Randell, P. A., & Moyle, G. J. (2009) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e318192116f · Cited by 12
Monitoring HIV-infected Patients with Diabetes: Hemoglobin A1c, Fructosamine, or Glucose?
Kim, S. Y., Friedmann, P., Seth, A., & Fleckman, A. M. (2014) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.4137/cmed.s19202 · Cited by 14
Effects of Pitavastatin on Lipid Profiles in HIV-Infected Patients with Dyslipidemia and Receiving Atazanavir/Ritonavir: A Randomized, Double-Blind, Crossover Study
Wongprikorn, A., Sukasem, C., Puangpetch, A., Numthavej, P., Thakkinstian, A., & Kiertiburanakul, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157531 · Cited by 11
Integrating hypertension screening at the time of voluntary HIV testing among adults in South Africa
Drain, P. K., Hong, T., Hajat, A., Krows, M. L., Govere, S., Thulare, H., Moosa, M. Y. S., Bassett, I. V., & Celum, C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210161 · Cited by 11
New and emerging agents in the management of lipodystrophy in HIV-infected patients
Bonnet, É. (2010) · HIV/AIDS - Research and Palliative Care · doi:10.2147/hiv.s13429 · Cited by 11
Analysis of Suppressor and Non-Suppressor FOXP3+ T Cells in HIV-1-Infected Patients
Arruvito, L., Sabatté, J., Pandolfi, J., Baz, P., Billordo, L. A., Lasala, M. B., Salomón, H., Geffner, J. R., & Fainboim, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052580 · Cited by 10
Predicting the risk of atherosclerotic cardiovascular disease among adults living with HIV/AIDS in Addis Ababa, Ethiopia: A hospital-based study
Woldu, M. A., Minzi, O., Shibeshi, W., Shewaamare, A., & Engidawork, E. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260109 · Cited by 10
Randomised controlled pilot study to assess the feasibility of a Mediterranean Portfolio dietary intervention for cardiovascular risk reduction in HIV dyslipidaemia: a study protocol
Stradling, C., Thomas, G. N., Hemming, K., Frost, G. S., García‐Pérez, I., Redwood, S., & Taheri, S. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010821 · Cited by 10
Bone Disease in HIV: Recommendations for Screening and Management in the Older Patient
Hoy, J. (2015) · Drugs & Aging · doi:10.1007/s40266-015-0279-4 · Cited by 10
Lipodystrophy Syndromes
Tsoukas, M. A., & Mantzoros, C. S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00037-8 · Cited by 10
Screening and management of renal disease in human immunodeficiency virus‐infected patients in A ustralia
Gracey, D. M., Chan, D. J., Bailey, M., Richards, D., & Dalton, B. S. (2012) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2012.02933.x · Cited by 8
Immediate versus Delayed Surgical Intervention for Reconstructive Therapy of HIV-Associated Facial Lipoatrophy: A Randomized Open-Label Study
Narciso, P., Bucciardini, R., Tozzi, V., Bellagamba, R., Ivanović, J., Giulianelli, M., Scevola, S., Palummieri, A., Fragola, V., Massella, M., et al. (2009) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2009.0029 · Cited by 9
Consumo alimentar e risco cardiovascularem pessoas vivendo com HIV/AIDS
Deresz, L. F., de Brito, C., Schneider, C. D., Rabito, E. I., Ikeda, M. L. R., & Lago, P. D. (2018) · Ciência & Saúde Coletiva · doi:10.1590/1413-81232018238.20542016 · Cited by 9
Documento de consenso: Recomendaciones para el manejo de la enfermedad ósea metabólica en pacientes con virus de la inmunodeficiencia humana
Martínez, E., Gimeno, E. J., Reyes‐García, R., Carpintero, P., Casado, J. L., Montes, J. D. P., Domingo, P., Estrada, V., Malouf, J., Negredo, E., et al. (2013) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2013.07.008 · Cited by 8
Evaluación del riesgo cardiovascular e intervención en los pacientes con VIH
Hernández, S., Vidal, M., & Pedrol, E. (2009) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(09)73444-5 · Cited by 9
Coverage of Sex Acts by Event-Driven Pre-exposure Prophylaxis: A Sub-Study of the ANRS IPERGAY Trial
ANRS IPERGAY Study Group, Bauer, R., Netzer, E., Pintado, C., Capitant, C., Cua, É., Etien, N., Fonsart, J., Pialoux, G., Chidiac, C., et al. (2020) · AIDS and Behavior · doi:10.1007/s10461-020-02890-6 · Cited by 8
O papel do hormônio de crescimento no tratamento dos distúrbios endócrino-metabólicos do paciente com a síndrome da imunodeficiência adquirida (Aids)
Spinola‐Castro, A. M., Siviero‐Miachon, A. A., da Silva, M. T. N., & Guerra‐Júnior, G. (2008) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302008000500014 · Cited by 8
Efficacy of Smoking Cessation Interventions among People with HIV in Kenya
Himelhoch, S. S., Koech, E., Omanya, A. A., Oduor, P., Mchembere, W., Masai, T. W., Bennett, M. E., Li, L., Potts, W., Ojoo, S. A., et al. (2024) · NEJM Evidence · doi:10.1056/evidoa2400090 · Cited by 7
Surrogate markers of visceral adipose tissue in treated HIV ‐infected patients: accuracy of waist circumference determination
Falutz, J., Rosenthall, L., Kotler, D. P., Zona, S., & Guaraldi, G. (2013) · HIV Medicine · doi:10.1111/hiv.12085 · Cited by 7
Self-citation
Implementing screening for hypertension in archetypal HIV primary care: a mixed-methods assessment
Buzaalirwa, L., Nambala, L., Banturaki, G., Amor, P. I., Katahoire, A., Geng, E. H., & Semeere, A. (2022) · BMC Health Services Research · doi:10.1186/s12913-022-08362-y · Cited by 7
Optimizing behavioral and pharmacological smoking cessation interventions among people with HIV
Himelhoch, S. S., Kelly, D. L., deFilippi, C. R., Taylor, G. H., Bennett, M. E., Medoff, D. R., Li, L., Christenson, R. H., Potts, W., & Shuter, J. (2023) · AIDS · doi:10.1097/qad.0000000000003821 · Cited by 7
Cardiovascular Risk Assessment for Persons Living With HIV
Burke, E. G., Nelson, J., Kwong, J. J., & Cook, P. F. (2011) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/j.jana.2011.05.007 · Cited by 7
Overview of HIV-related lipodystrophy
Rossouw, T. M., Botes, M., & Conradie, F. (2013) · Southern African Journal of HIV Medicine · doi:10.7196/sajhivmed.871 · Cited by 7
Risco cardiovascular: marcadores antropométricos, clínicos e dietéticos em indivíduos infectados pelo vírus HIV
Leite, L. H. M., & Sampaio, A. B. D. M. M. (2011) · Revista de Nutrição · doi:10.1590/s1415-52732011000100008 · Cited by 7
Subcutaneous Fat
McGibbon, D. (2010) · doi:10.1002/9781444317633.ch46 · Cited by 7
Changes in lipid profiles after switching to a protease inhibitor-containing cART - unfavourable effect of fosamprenavir in obese patients
Gyalrong-Steur, M., Bogner, J. R., & Seybold, U. (2011) · European journal of medical research · doi:10.1186/2047-783x-16-2-85 · Cited by 6
Objective amount of limb fat in HIV‐infected subjects with subjective diagnosis of lipoatrophy
Martínez, E., Larrousse, M., Podzamczer, D., & Gatell, J. M. (2009) · HIV Medicine · doi:10.1111/j.1468-1293.2008.00680.x · Cited by 6
Pharmacokinetics, protein‐binding‐adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment‐naïve HIV‐infected patients*
Lambert-Niclot, S., Machouf, N., Peytavin, G., Soulié, C., Wirden, M., Simon, A., Murphy, R. L., Katlama, C., Thomas, R., Cálvez, V., et al. (2010) · HIV Medicine · doi:10.1111/j.1468-1293.2010.00839.x · Cited by 6
Self-citation
[Assessment and management of kidney disease in the HIV-1-infected patient. A practical review].
Domingo, P., Knobel, H., Gutiérrez, F., Barril, G., & Fulladosa, X. (2010) · Enfermedades Infecciosas y Microbiologia Clinica · doi:10.1016/j.eimc.2009.05.004 · Cited by 6
Efectos adversos de atazanavir
Palacios, R., González, M., Ruiz, J., & Santos, J. (2008) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(08)76619-9 · Cited by 6
Drug therapies for HIV-related metabolic disorders
Lamarca, K., Sarasola, A. G., Vidal, F., & Domingo, P. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1187133 · Cited by 6
Diabetes and Infections
Cockram, C. S., & Lee, N. L. S. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch50 · Cited by 6
Dislipidemia y virus de inmunodeficiencia adquirida/sida
Elías-Calles, L. C., & Calero, T. M. G. (2010) · Revista cubana de endocrinología · Cited by 5
Evaluation of some immune and inflammatory responses in diabetes and HIV co-morbidity
Chukwuanukwu, R. C., Nwosu, N., Ositadinma, I. M., Nsonwu-Anyanwu, A. C., & Manafa, P. (2023) · African Health Sciences · doi:10.4314/ahs.v23i1.14 · Cited by 5
Clinical Management Considerations for Dyslipidemia in HIV–Infected Individuals
Kirchner, J. T. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.01.2515 · Cited by 5
Tratamiento de las dislipemias en situaciones especiales
Goya, I. L., & Bueno, M. M. (2012) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(12)70042-0 · Cited by 6
Papel del farmacéutico de hospital en la prevención, identificación y manejo de los efectos adversos asociados al tratamiento antirretroviral
Morillo‐Verdugo, R., Lisón, L. C. F., Fernandez, M. J., Conde, M. T. M., Morales, J. C. R., Camps, R. R., Hazas, J. I. S. L. D. L., Barrueta, O. I., & Uranga, A. I. (2010) · Farmacia Hospitalaria · doi:10.1016/j.farma.2010.01.012 · Cited by 5
Cost Effectiveness of Darunavir/ritonavir Combination Antiretroviral Therapy for Treatment-Naive Adults with HIV-1 Infection in Canada
Brogan, A. J., SMETS, E. F., Mauskopf, J., Manuel, S. A. L., & Adriaenssen, I. (2014) · PharmacoEconomics · doi:10.1007/s40273-014-0173-7 · Cited by 5
Glycemic Control Among People Living with Diabetes and Human Immunodeficiency Virus in Ethiopia: Leveraging Clinical Care for the Looming Co-Epidemics
Melaku, T., Chelkeba, L., Mekonnen, Z., & Kumela, K. (2020) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s266105 · Cited by 4
Recreational Exercising and Self-Reported Cardiometabolic Diseases in German People Living with HIV: A Cross-Sectional Study
Chaparro, C. G. A. P., Schuch, F. B., Zech, P. A., Kangas, M., Rapp, M. A., & Heißel, A. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182111579 · Cited by 4
Low incidence of advanced neurological burden but high incidence of age-related conditions that are dementia risk factors in aging people living with HIV: a data-linkage 10-year follow-up study
Aung, H. L., Bloch, M. T., Vincent, T., Mao, L., Brew, B. J., & Cysique, L. A. (2022) · Journal of NeuroVirology · doi:10.1007/s13365-022-01104-0 · Cited by 4
Oral Health and HIV Infection: A Chronic Disease Model
Younai, F. S., & Vincent-Jones, C. (2009) · Journal of the California Dental Association · doi:10.1080/19424396.2009.12223036 · Cited by 4
Guidelines for managing cardiovascular risk: an evolving area
Currier, J. S., & Lundgren, J. D. (2008) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e3282fc75fe · Cited by 4
Self-citation
Lipodystrophy Syndromes
Gao, C., & Mantzoros, C. S. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00038-1 · Cited by 4
Drug-drug interactions in HIV medicine: a not so simple and straightforward road to the future
Tsiodras, S., & Mantzoros, C. S. (2011) · Metabolism · doi:10.1016/j.metabol.2011.05.022 · Cited by 3
The additive effect of type 2 diabetes on fibrinogen, von Willebrand factor, tryptophan and threonine in people living with HIV
Harrison, M., Wolfe, A. S., Fordyce, J., Rock, J. L., García, A. A., & Zuniga, J. A. (2019) · Amino Acids · doi:10.1007/s00726-019-02715-4 · Cited by 3
Defining the optimum HOMA-IR cut-off value for insulin resistance among ARV-treated HIV patients in Indonesia
Harbuwono, D. S., Nenfiati, Tahapary, D. L., Setiati, S., Yunihastuti, E., & Tarigan, T. J. E. (2023) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2023.102719 · Cited by 3
Chemometrics as a valuable tool for evaluating interactions between antiretroviral drugs and food
Wiesner, A., Zagrodzki, P., Jamrozik, M., Korchowiec, J., Marcinkowska, M., & Paśko, P. (2023) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15796 · Cited by 3
Simplification from Twice-Daily to Once-Daily Darunavir/Ritonavir in a Randomized Trial among HIV-Infected Persons with HIV-1 RNA Suppression on Antiretroviral Therapy
Huhn, G. D., Sigman, A., & Livak, B. (2014) · Antiviral Therapy · doi:10.3851/imp2962 · Cited by 3
Determinants of developing widened spatial QRS-T angle in HIV-infected individuals: Results from the Strategies for Management of Antiretroviral Therapy [SMART] Study
Dawood, F. Z., Roediger, M. P., Grandits, G., Miller, D., Fisher, M., Zhang, Z., Hodder, S., Hoy, J., Lundgren, J. D., Neaton, J. D., et al. (2013) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2013.12.001 · Cited by 3
Self-citation
Overview of HIV-related lipodystrophy
Rossouw, T. M., Botes, M., & Conradie, F. (2013) · Southern African Journal of HIV Medicine · doi:10.4102/sajhivmed.v14i1.100 · Cited by 3
Dyslipidemia in HIV-Infected Patients
Lee, F. J., & Carr, A. D. (2015) · Contemporary Endocrinology · doi:10.1007/978-1-60761-424-1_9 · Cited by 3
Bisphosphonates in the treatment of HIV-related osteoporosis
Vescini, F., & Grimaldi, F. (2014) · Endocrine · doi:10.1007/s12020-014-0488-3 · Cited by 3
Pharmacological interventions for treating dyslipidemia in patients with HIV infection
Martí-Carvajal, A. J., & Cruciani, M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008869 · Cited by 2
Retracted
Nephropathies in HIV-infected patients: an overview
Lai, S., Mariotti, A., Lai, C. P. T., Testorio, M., Carta, M., Innico, G., Frassetti, N., & Russo, G. (2013) · OA Nephrology · doi:10.13172/2053-0293-1-2-782 · Cited by 2
Evolución de la fibrosis hepática en reclusos coinfectados por VIH y VHC que inician tratamiento con inhibidores de la proteasa potenciados
Zamácola, P. S. D. L. H., Alía, C., Marco, A., Burgos, A. L., Ramirez, J. D. J., Matías, A. H., & Sogorb, J. P. (2013) · Revista Española de Sanidad Penitenciaria · doi:10.4321/s1575-06202013000200003 · Cited by 2
Perfil lipídico de atazanavir
Martínez, E. (2008) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(08)76618-7 · Cited by 2
Zidovudine
Kennedy, R. D., & McGoldrick, C. (2015) · Practical Diabetes · doi:10.1002/pdi.1929 · Cited by 1
Uso del índice tobillo-brazo en la reclasificación del riesgo vascular en pacientes con infección VIH
Olalla, J., Salas, D., Lima, J. D. L. T., del Arco, A., Prada, J. L., & Alegría, J. G. (2011) · Revista médica de Chile · doi:10.4067/s0034-98872011000800009 · Cited by 1
Lipid Changes in Virologically Suppressed HIV-Infected Patients Switching from any Antiretroviral Therapy to the Emtricitabine/Rilpivirine/Tenofovir Single Tablet
Palacios, R., Mayorga, M., Pérez‐Hernández, I. A., Rivero, A., del Arco, A., Lozano, F., Santos, J., & GESIDA-8114-LIRA Study Group (2016) · Journal of the International Association of Providers of AIDS Care (JIAPAC) · doi:10.1177/2325957416629785 · Cited by 1
Epidemiology and Clinical Approach to Heart Failure in Patients with HIV
Al-Kindi, S. G., & Longenecker, C. T. (2019) · Springer eBooks · doi:10.1007/978-3-030-10451-1_10 · Cited by 1
Dyslipidemia in HIV
Dubé, M. P. (2015) · Springer eBooks · doi:10.1007/978-3-319-11161-2_14 · Cited by 1
Characteristics of Older Patient with Haemophilia
Zupani, S., Boban, A., & Pulani, D. (2012) · InTech eBooks · doi:10.5772/28547 · Cited by 1
Enfermedad cardiovascular en el paciente infectado por el virus de la inmunodeficiencia humana
Larrousse, M., & Martínez, E. (2010) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2009.02.006 · Cited by 1
Lipid Management in Human Immunodeficiency Virus
Myerson, M. L. (2015) · Cardiology Clinics · doi:10.1016/j.ccl.2015.01.003 · Cited by 1
Osteoporosis en los pacientes infectados por el virus de la inmunodeficiencia humana
Gullón, A., & García-Vadillo, A. (2013) · Seminarios de la Fundación Española de Reumatología · doi:10.1016/j.semreu.2012.11.001 · Cited by 1
HIV and Stroke
Sen, S., Giamberardino, L. D., & Thakker, P. U. (2017) · Springer eBooks · doi:10.1007/978-1-4939-7290-6_23 · Cited by 1
The Nutritional Management of Complications Associated with HIV and Antiretroviral Therapy
Duncan, A., & Klassen, K. (2010) · doi:10.1002/9781118786529.ch10 · Cited by 1
Measures of physical function as risk factors for diabetes mellitus and insulin resistance among HIV-uninfected and HIV-infected men
Longenberger, A. H. (2009) · D-Scholarship@Pitt (University of Pittsburgh)
Complications Resulting from Antiretroviral Therapy for HIV Infection
Nolan, D. A., Mallal, S. A., & Reiss, P. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-2882-6.50021-6
Self-citation
TMC278 (Rilpivirine): A Next‐Generation NNRTI in Phase III Clinical Development for Treatment‐Naive Patients
Guillemont, J., Boven, K., Crauwels, H. M., & de Béthune, M. (2011) · doi:10.1002/9780470929353.ch5
Cost of surgical intervention for reconstructive therapy of HIV-associated facial lipoatrophy
Massella, M. (2011) · Patient Preference and Adherence · doi:10.2147/ppa.s16819
Vitamine D et foie
Toulemonde, P. (2015) · HEGEL - HEpato-GastroEntérologie Libérale · doi:10.3917/heg.051.0010
Initiating and maintaining HAART - aiming for the long term in treatment-naive patients
Behrens, G. M. N. (2009) · International Journal of STD & AIDS · doi:10.1258/ijsa.2009.09s003
Self-citation
From lipodystrophy to cardiovascular disease: new insight into the management of HIV infection
Guaraldi, G., & Zona, S. (2010) · Clinical Lipidology · doi:10.2217/clp.10.32
Self-citation
Nutritional Screening and Assessment
Woodman, S., Sutcliffe, M., & McDonald, A. (2010) · doi:10.1002/9781118786529.ch8
Srce i krvni Sudovi
Beleslin, B., Deljanin, M., Kanjuh, V., Parapid, B. J., Giga, V. L., Prostran, M. S., Angelkov, L., Balinovac, J., Bikicki, M., Ambrosio, G., et al. (2013)
UNIVERSIDADE FEDERAL DE GOIÁS PROGRAMA DE PÓS-GRADUAÇÃO EM MEDICINA TROPICAL
Pública, E. S., Ribeiro, P. M. A., & Pacheco, G. (2010)
MENTION : SCIENCES, TECHNOLOGIE, SANTE OPTION : EPIDEMIOLOGIE ET SANTE PUBLIQUE
Bénard, A. (2009)
Treatment of Persons Infected with the Human Immunodeficiency Virus
Powderly, W. G., & Overton, E. T. (2009) · Elsevier eBooks · doi:10.1016/b978-0-323-05674-8.50217-6
Self-citation
Dietary Intervention for Dyslipidemia in Human Immunodeficiency Virus Infection
Bello, A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800769-3.00023-8
UNIVERSIDADE FEDERAL DO ESPÍRITO SANTO CENTRO DE CIÊNCIAS DA SAÚDE PROGRAMA DE PÓS-GRADUACAO EM DOENÇAS INFECCIOSAS
Silva, L. F. D., & Neto, P. G. F. (2012)
Prevention of type 2 diabetes in people living with HIV : understanding risk factors, and investigating the effectiveness and acceptability of a lifestyle intervention
Duncan, A. (2016) · Research Portal (King's College London)
Voeding bij hiv en aids
Bruynzeel, P., Jonkers‐Schuitema, C. F., van Eden, J., & van Vugt, M. (2013) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-0508-7_68
Metabolic Complications Associated with HIV and Highly Active Antiretroviral Therapy : Overview & A Clinical Case Report
Choi, E. J., & Graham, K. K. (2012) · Korean Journal of Clinical Pharmacy
Human Immunodeficiency Virus Infection: Spectrum of Rheumatic Manifestations
Vega, L. E., & Espinoza, L. R. (2019) · Springer eBooks · doi:10.1007/978-3-030-23311-2_15
Complications resulting from antiretroviral therapy for HIV infection
Nolan, D. A., Mallal, S. A., & Reiss, P. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0695-2.00014-6
Self-citation
How to manage hyperlipidemia in the HIV patient
Currier, J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-04579-7.00247-1
Seminarios de la Fundación Española de Reumatología
de Jesus, M. C. P., Arias, G., Alberto, J., & García-Vadillo, A. (2016)

Authors: Lundgren, J., Battegay, M., Behrens, G., De Wit, S., Guaraldi, G., Katlama, C., Martinez, E., Nair, D., Powderly, W., Reiss, P., Sutinen, J., Vigano, A., & the EACS Executive Committee
Affiliations: University Hospital of Basel (CH)
Medizinische Hochschule Hannover (DE)
University of Modena and Reggio Emilia (IT)
Pitié-Salpêtrière Hospital (FR)
The Royal Free Hospital (GB)
Amsterdam UMC Location University of Amsterdam (NL)
Helsinki University Hospital (FI)
ORCID: Battegay, M
Behrens, G
Guaraldi, G
Katlama, C
Nair, D
Reiss, P
Venue: HIV Medicine
Publisher: Wiley
Published: 2008-01-31
Volume: 9
Issue: 2
Pages: 72-81
ISSN: 1464-2662 (ISSN-L)
1468-1293
DOI: 10.1111/j.1468-1293.2007.00534.x
OpenAlex: W2032218832
Cited by: 210
References: 18
Citations by year: 2026: 1 · 2025: 1 · 2024: 3 · 2023: 4 · 2022: 4 · 2021: 5 · 2020: 5 · 2019: 9 · 2018: 5 · 2017: 8 · 2016: 14 · 2015: 14 · 2014: 13 · 2013: 22 · 2012: 19
FWCI: 30.19
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: HIV Medicine (publishedVersion)
PubMed (publishedVersion)
Pure Amsterdam UMC (publishedVersion)
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion)
IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
INFM-OAR (INFN Catania) (submittedVersion, other-oa)
Topics: Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Keywords: dyslipidemia, type 2 diabetes, hypertension, lipoatrophy, intra-abdominal fat, cardiovascular risk, antiretroviral therapy, lipid-lowering therapy, lifestyle intervention, body composition, renal function, pharmacokinetic interactions, medication adherence, screening
MeSH terms: Cardiovascular Diseases, Drug Interactions, Humans, Life Style, Metabolic Diseases, HIV Infections, Polypharmacy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV*

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks